Concert Pharmaceuticals
Dr. Cameron Cowden joined Concert in January 2016 and currently serves as Vice President, Pharmaceutical Development. He has nearly 20 years of process chemistry and chemical engineering experience in the pharmaceutical industry. Prior to joining Concert, Dr. Cowden was an Executive Director in Process Chemistry at Merck. He received his Ph.D. from the University of Melbourne, Australia and was a postdoctoral fellow at Cambridge University in the United Kingdom.
This person is not in any offices
Concert Pharmaceuticals
Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs.